Skip to content

A clinical trial to study the effects of two drugs, saraswata ghrita and masha taila in patients with hearing loss.

A comparative clinical study to evaluate the efficacy of masha taila karnapoorana and masha taila karnapoorana with saraswata ghrita internally in badhirya with special referrence to sensorineural hearing loss. - NIL

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/10/074966
Enrollment
40
Registered
2024-10-09
Start date
Unknown
Completion date
Unknown
Last updated
2024-10-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H818- Other disorders of vestibular function

Interventions

None listed

Sponsors

Dr Amrutha K
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Patients with mild to moderate sensorineural hearing loss. 2)Age groups between 25-60 years. 3)Patients with intact tympanic membrane. 4)Patients of either gender.

Exclusion criteria

Exclusion criteria: 1)Congenital sensorineural hearing loss. 2)Patients with conducting hearing loss. 3)Patients with Tinnitus, Vertigo, Otorrhea. 4)Patients with other systemic diseases. 5)Pregnant and lactating women.

Design outcomes

Primary

MeasureTime frame
PURE TONE AUDIOMETRY (PTA)Timepoint: 58 days

Secondary

MeasureTime frame
HEARING LOSSTimepoint: 58 days

Countries

India

Contacts

Public ContactDr Syed Munawar Pasha

Government Ayurveda Medical College, Bengaluru

smpasha78@gmail.com9886593932

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026